KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
$ka [15s. delayed]: issued press release on april 17, 06:30:00: kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time